Neev Mehta (@MbbsMehta) header
Neev Mehta (@MbbsMehta) profile picture

MD MPH, PGY-4, Chief Resident IM @Lahey_Clinic | GI Research @Lahey_Clinic |MD @Themsubaroda| Public health @BUSPH

Joined July 2013
Photo by Neev Mehta (@MbbsMehta)Photo by Neev Mehta (@MbbsMehta)Photo by Neev Mehta (@MbbsMehta)Photo by Neev Mehta (@MbbsMehta)Photo by Neev Mehta (@MbbsMehta)Photo by Neev Mehta (@MbbsMehta)Photo by Neev Mehta (@MbbsMehta)Photo by Neev Mehta (@MbbsMehta)
Neev Mehta retweeted
Finally, a global consensus on #ACLF criteria and severity ! It will help large-scale observational studies and better international clinical trials. @EASLnews @AASLDtweets @APASLnews @alehlatam @Solda_Society
3
46
111
4,740
Why do some UC patients fail vedolizumab (VDZ)? A landmark study in Nature Medicine by Schreiber et al. unpacks the biological mechanism of VDZ resistance: revealing an alternative vascular bypass that might be targetable with common medications
7
48
11
116
20,650
🏔️ Taking liver research to new heights—literally! Had a great #TLM2026 in Denver with a Poster of Distinction and an Oral Presentation! Beyond grateful to the Lahey Transplant team and my amazing mentors for helping me reach new heights! 🩺✨ #AASLD #LaheyTransplant
1
1
1
9
666
Wrapping up the last day at #TLM2026 after presenting one poster and one oral abstract 🎤📊 It’s been a productive and memorable meeting. So grateful to the Lahey team and all my mentors for their support along the way 🧡👏
1
3
1
14
1,078
📢 Catch our LFN members presenting their exciting research today at TLM! 🗓️ Thursday, Nov 5 ⏰ 12–1 PM MT 📍 Poster Session Stop by, support your colleagues, and join the conversation! 👏 #AASLD #LiverTwitter
4
16
1,133
At the RA-MD 11th Meeting 2026, presented a unique case- advanced fibrotic ILD with coexisting IPAF and short telomere syndrome. 🧬Telomere biology disorders are an underrecognized cause of progressive fibrotic ILD. Watch for early onset, rapid decline, and premature graying.
1
1
7
179
🚨 Update to OMIGuide! Huge shoutout to Mriganka Nerkar, MS4, who led a major expansion of the guide - adding 100+ new cases from Dr. Smith’s ECG Blog since our original launch in 2023! Check out the updates at omiguide.org @smithECGBlog @PendellM @WillyFrick
3
54
1
189
46,769
What an excellent thread for new trainees looking to do research in residency!
1/ My first paper in PGY2 residency landed in JAMA Oncology, and the truth is it was won before I ran a single analysis. It came down to how I chose the question. 8 Years later, I realized that very few trainees got taught about how to pick a first research idea. Lets try a bit
1
210
1/ My first paper in PGY2 residency landed in JAMA Oncology, and the truth is it was won before I ran a single analysis. It came down to how I chose the question. 8 Years later, I realized that very few trainees got taught about how to pick a first research idea. Lets try a bit
7
66
10
434
87,654
Had a gut feeling this poster would land well. #DDW2026 Chicago edition 2023: nervous first-timer with a poster 📄 2026: still nervous, but in Chicago 🏙️ Both times: walked away inspired, humbled, and with new connections and ideas. #Grateful #GITwitter #Gastroenterology
1
1
7
296
Prophylaxis of SBP is dying But if you still insist, then please do NOT continue the same antibiotic after an episode of SBP. This happens 80% of the time according to a new study. Bananas!!! Just because cipro is in the guidelines does not mean it’s the only one you can use.
1
59
1
283
21,551
Cirrhosis is diagnosed too late. Routine ECG + AI can do more than assess the heart in primary care, now in @NatureMedicine 🫀15,596 patients with ECG 🏥Pragmatic randomized trial 📈Increased detection of liver disease 💡Scalable, low-cost screening nature.com/articles/s41591-0…
7
41
3
140
27,267
Neev Mehta retweeted
Data are very weak. doi.org/10.1093/cid/ciaf047
Time to rethink SBP prophylaxis? Antibiotic prophylaxis for SBP in cirrhosis has been standard since the 1990s—but the new 🔥ASEPTIC trial, presented at #TLM25, just challenged that. 📊 Bactrim vs placebo in cirrhosis + ascites (no prior SBP): ➡️ No survival benefit for primary prophylaxis Maybe it’s time to revisit this long-standing practice!
3
55
2
187
34,821
Loved interacting with residents and diving into all things endoscopy! Thank you @AmCollegeGastro @IBD_Afzali for the opportunity! #GITwitter #MedTwitter #ACG2025
2
13
1,054
The tradition continues! 
✅ ACG 2022
✅ ACG 2024
✅ ACG 2025 Grateful for another incredible #ACG experience — learning, connecting, and being inspired by the brightest minds in GI. Leaving more empowered and motivated than ever! #Gastroenterology #MedTwitter #ACG2025
2
3
28
2,502
Perioperative risk assessment and management in patients with cirrhosis: new clinical guidelines from @AmCollegeGastro 🆕✂️ 📸: journals.lww.com/ajg/fulltex…
2
123
3
377
46,162